Skip to content
Home/Companies/MedTech/Axion Biosystems

Axion Biosystems

MedTech·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Axion Biosystems?

Axion Biosystems is currently owned by Summa Equity through Summa Equity Fund II (2019 vintage), since 2021.

Hand-verified · updated 2026-08-18

Summa Equity
Investor
Summa Equity
Summa Equity Fund II · 2019 · Buyout

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Summa Equity Fund II

Other portfolio companies in the same fund.

G-CON Manufacturing
Exited 2025
HealthcareUS· 2021
to
Holdbart
Active
ConsumerNorway· 2021
myneva
myneva
Active
SoftwareGermany· 2021
Nofitech
Active
IndustrialsNorway· 2021
Sengenics
Active
BiotechSingapore· 2020
Infobric
Infobric
Exited 2025
SoftwareSweden· 2019
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Axion Biosystems

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Axion Biosystems?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Axion Biosystems.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue